Home » Topics » BioWorld Science, Conferences

BioWorld Science, Conferences
RSS

GnRH antagonist elagolix sodium improves endometriosis symptoms in Petal study

Oct. 20, 2009

K-101 topical solution eradicates infection in adults with distal subungual onychomycosis

Oct. 20, 2009

BIBF-1120 maintenance therapy may delay disease progression in ovarian cancer

Oct. 20, 2009

Phase II data for p53-SLP vaccine in ovarian cancer reported

Oct. 20, 2009

Inhaled AIR-645 well tolerated in phase I study

Oct. 20, 2009

Cenomed BioSciences presents anti-emetic candidate devoid of anxiogenic effects

Oct. 19, 2009

A-940894 shows potent in vivo/in vitro anti-inflammatory activity

Oct. 19, 2009

Anti-Fas IgM monoclonal antibody ARG-098 decreases rheumatoid arthritis activity

Oct. 19, 2009

Selective glucocorticoid receptor modulator has less effect on bone biomarkers

Oct. 19, 2009

Medarex releases full phase II results with MDX-100 in rheumatoid arthritis

Oct. 19, 2009

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 14, 2026.
AAIC 2026: Age of amyloid is being joined by time of tau
BioWorld
The Alzheimer’s Association International Conference (AAIC) is the world’s biggest dementia conference. And at the AAIC 2026 meeting, there is big buzz around...
Neurovalens granted FDA approval for PTSD therapy for US veterans
BioWorld
Veterans in the U.S. suffering from post-traumatic stress disorder (PTSD) now have access to Neurovalens Ltd.’s Modius Spero, a wearable neuromodulation device,...
News in brief
BioWorld Asia
BioWorld Asia briefs for July 14, 2026
Celia trial: data strong, analysts skeptical
BioWorld
Tuesday brought what was arguably the most anticipated presentation of the 2026 Alzheimer’s Association International Conference when Catherine Mummery, head of...